Informaは企業と専門家を数百の方法でサポートしています。

私たちの国際的なライブイベント、世界をリードする研究出版物、革新的なデジタルサービスのポートフォリオは、専門家が成功するために必要な知識と人脈を提供しています。

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Hideki Tomioka, PhD
FunPep Co., Ltd. における Director of the Board and CSO
スピーカー

プロフィール

Hideki Tomioka, Ph.D. is the CSO of FunPep Co., Ltd.. He currently leads an active pipeline of chronic disease immunotherapeutic candidates including for Psoriasis, Ankylosing spondylitis and Pollinosis. He graduated from Graduate School of Pharmaceutical Sciences, Tokyo University of Science in March 1997. He was employed in Ono Pharmaceutical Co., Ltd. from 1997 to 2005. He worked as a researcher at AnGes MG, Inc. from 2005 to 2015. He received his Ph.D from Graduate School of Medicine, Osaka University in 2014. He joined FunPep Co., Ltd.in 2015. His research interests the functional peptides.

アジェンダセッション

  • Antibody-inducing Peptide Using Universal Epitopes: Concept and Clinical Update

    3:45pm